JPS61207315A - External agent for skin - Google Patents

External agent for skin

Info

Publication number
JPS61207315A
JPS61207315A JP60049662A JP4966285A JPS61207315A JP S61207315 A JPS61207315 A JP S61207315A JP 60049662 A JP60049662 A JP 60049662A JP 4966285 A JP4966285 A JP 4966285A JP S61207315 A JPS61207315 A JP S61207315A
Authority
JP
Japan
Prior art keywords
skin
placenta
residue
extract
external agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60049662A
Other languages
Japanese (ja)
Inventor
Yoshimori Fujinuma
好守 藤沼
Hidekazu Toyoda
豊田 英一
Shuya Tamaoki
玉置 修哉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP60049662A priority Critical patent/JPS61207315A/en
Publication of JPS61207315A publication Critical patent/JPS61207315A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE:To provide an external agent for skin, having synergistically improved skin-beautifying effect and high safety and effective remarkably to stains, freckles, dark skin, etc., by using extract of placenta and a hydroquinone glycoside as active components. CONSTITUTION:The objective external agent for skin contains (A) 0.001-5wt% extract of placenta (in terms of dried solid) and (B) 6-20wt% hydroquinone glycoside of formula (R is pentose residue, hexose residue, amino sugar residue, uronic acid residue or their methylated products). It has remarkably improved skin-beautifying effect and high safety and is used in various forms such as skin lotion, milky lotion, cream, ointment, etc. The extract of placenta is e.g. dried powder, carbonized product, hydrolyzed product, hot extract or extracted liquid of animal placenta or human placenta.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は皮膚美白効果が著しく改良された安全性の高い
皮膚外用剤に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a highly safe external skin preparation with significantly improved skin whitening effects.

[従来の技術] 皮膚のしみなどの発生機序については不明な点もあるが
、一般には、ホルモンの異常や日光からの紫外線の刺激
が原因となってメラニン色素が形成され、これが皮膚内
に異常沈着するものと考えられている。このようなしみ
やあざの治療法にはメラニンの生成を抑制する物質、例
えばビタミンCを大量に投与する方法、グルタチオン等
を注射する方法あるいはL−アスコルビン酸、システィ
ンなどを軟膏、クリーム、ローションなどの形態にして
、局所に塗布するなどの方法がとられている。
[Conventional technology] Although there are some points that are unclear about the mechanism by which skin spots occur, in general, melanin pigments are formed due to hormonal abnormalities or stimulation of ultraviolet rays from sunlight, and this is caused by the formation of melanin within the skin. It is thought that it is abnormally deposited. Treatments for these spots and bruises include administering large amounts of substances that inhibit melanin production, such as large doses of vitamin C, injections of glutathione, or the use of ointments, creams, and lotions containing L-ascorbic acid, cysteine, etc. Methods such as making it into a form and applying it locally are used.

[発明が解決しようとする問題点] しかしながら、これらのものの多くは、安定性、安全性
、匂い等の面において問題があり、また期待できる効果
は弱く、未だ満足のいくものではなかった。
[Problems to be Solved by the Invention] However, many of these products have problems in terms of stability, safety, odor, etc., and the expected effects are weak, so they are not yet satisfactory.

本発明者等は、このような事情に鑑み、真に優れた美白
効果を有する皮膚外用剤を得るべく鋭意研究を重ねた結
果、胎盤抽出物と、下記一般式であらわされるハイドロ
キノンの配糖体 [式中、Rは豆炭糖残基、六Qtm残基、アミノ糖残基
、ウロン酸残基又はそれらのメチル化物を示す。] とを皮膚外用剤に配合することによりしみ、そばかす、
色黒などが著しく改善され美白効果が相乗的に増大する
ことを見出し、本発明を完成するに至った。
In view of these circumstances, the present inventors have conducted intensive research to obtain a skin external preparation with truly excellent whitening effects, and as a result, we have developed a placenta extract and a glycoside of hydroquinone represented by the following general formula. [Wherein, R represents a bean sugar residue, a hexaQtm residue, an amino sugar residue, a uronic acid residue, or a methylated product thereof. ] By incorporating this into external skin preparations, stains, freckles,
The present inventors have discovered that dark complexion is significantly improved and the whitening effect is synergistically enhanced, leading to the completion of the present invention.

[問題点を解決するための手段] すなわち、本発明は、胎盤抽出物と、上記一般式で表さ
れるハイドロキノンの配糖体とを、含有することを特徴
とする皮膚外用剤である。
[Means for Solving the Problems] That is, the present invention is an external skin preparation characterized by containing a placenta extract and a hydroquinone glycoside represented by the above general formula.

以下、本発明の構成について詳述する。  ・本発明で
使用する胎盤抽出物は、動物胎盤や被と胎盤の乾燥粉末
、炭化物、氷解物や加温抽出物、あるいは動物胎盤抽出
液や、胎盤抽出液等である。
Hereinafter, the configuration of the present invention will be explained in detail. - Placental extracts used in the present invention include dry powders, charred products, melted ice products, and heated extracts of animal placentas and placentas, animal placenta extracts, placenta extracts, and the like.

ここでいう抽出液とはその抽出方法は限定きれないが、
例を挙げて説明すると、例えば人胎盤をよく水洗、細砕
し、よく脱血し、これに精製水を加え、低温下ホモゲナ
イズを続けて抽出して得られる抽出液等である。市販品
としては動物胎盤抽出液である゛プラセンタリキッド(
Kurt Richter−壽ケミカル)、大胎盤抽出
液であるブラセナンドV(−丸貿易)およびブラセンA
F(三省製薬)等があげられる。
The extraction liquid referred to here is not limited to the extraction method, but
An example is an extract obtained by thoroughly washing a human placenta with water, pulverizing it, thoroughly removing blood, adding purified water, followed by homogenization at a low temperature. As a commercially available product, placenta liquid (an animal placenta extract) is available.
Kurt Richter-Ju Chemical), large placenta extract Brasenand V (-Maru Boeki) and Brasen A
Examples include F (Sansei Pharmaceutical).

本発明の皮膚外用剤にはこのうち4・ら一種又は二種以
上併用してもよい。
In the skin external preparation of the present invention, one or more of these four may be used in combination.

胎盤抽出液の配合量は、本発明の皮膚外用剤中、乾燥固
形分で0.001〜5重量%が好ましい。
The amount of placenta extract in the skin external preparation of the present invention is preferably 0.001 to 5% by weight on a dry solid basis.

0.001重量%未満では十分な効果かえられず、5%
程度で十分である。
If it is less than 0.001% by weight, sufficient effect cannot be obtained, and 5%
It is enough.

本発明に用いられるハイドロキノンの配糖体は下記一般
式であられきれる。
The hydroquinone glycoside used in the present invention can be represented by the following general formula.

E式中、Rは豆炭糖残基、六炭糖残基、アミノ糖残基、
ウロン酸残基又はそれらのメチル化物を示す。] 式中でRはL−アラビノース、D−アラビノース、D−
キシロース、D−リポース、L−キシルロース、L−リ
キソース、D−リブロースの石炭糖の残基、D−グルコ
ース、D−ガラクトース、L−ガラクトース、D−マン
ノース、D−タロース、D−フルクトース、L−ソルボ
ース、D−タガトース、D−プシコース等の六炭糖の残
基、D−グルコサミン、D−ガラクトサミン、シアル酸
、アミノウロン酸、ムラミン酸等のアミノ糖の残基、D
−グルクロン酸、D−ガラクツロン酸、D−マンヌロン
酸、L−イズロン酸、L−グルロン酸等のウロン酸の残
基又はそれらのメチル化物を示すが、美白効果、入手の
仕易き、安定性、安全性の両面からRがD−グルコース
がβ−結合した、すなわちハイドロキノン −D−グル
コース(一般名:アルブチン、以後アルブチンという)
が最も好ましい。
In formula E, R is a bean sugar residue, a hexose residue, an amino sugar residue,
Indicates uronic acid residues or their methylated products. ] In the formula, R is L-arabinose, D-arabinose, D-
Xylose, D-lipose, L-xylulose, L-lyxose, coal sugar residues of D-ribulose, D-glucose, D-galactose, L-galactose, D-mannose, D-talose, D-fructose, L- Hexose residues such as sorbose, D-tagatose, D-psicose, amino sugar residues such as D-glucosamine, D-galactosamine, sialic acid, aminouronic acid, muramic acid, D
- Refers to residues of uronic acids such as glucuronic acid, D-galacturonic acid, D-mannuronic acid, L-iduronic acid, and L-guluronic acid, or their methylated products, which have a whitening effect, easy availability, and stability. , from the viewpoint of safety, R is D-glucose β-bonded, that is, hydroquinone-D-glucose (generic name: arbutin, hereinafter referred to as arbutin).
is most preferred.

配合量は皮膚外用全量中の0.1−30重量%であり、
好ましくは6−20重量%である。
The blending amount is 0.1-30% by weight of the total amount for external use on the skin,
Preferably it is 6-20% by weight.

本発明の皮膚外用剤には上記した必須成分の他に通常化
粧品や医薬品等の皮膚外用剤に用いられる他の成分、例
えば油分、湿潤剤、紫外線吸収剤、酸化防止剤、界面活
性剤、防腐剤、保湿・剤、香料、水、アルコール、増粘
剤等を必要に応じて適宜配合することができる。
In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention contains other ingredients normally used in external skin preparations such as cosmetics and pharmaceuticals, such as oil, humectants, ultraviolet absorbers, antioxidants, surfactants, and preservatives. Agents, moisturizers, fragrances, water, alcohol, thickeners, etc. can be added as appropriate.

本発明に係る皮膚外用剤の剤型は任意であり、例えば化
粧水などの可溶化系、乳液、クリームなどの乳化系、又
は軟膏、分散液などの任意の剤型をとることができる。
The external preparation for skin according to the present invention may take any form, for example, a solubilized system such as a lotion, an emulsified system such as a milky lotion or cream, or an arbitrary dosage form such as an ointment or a dispersion.

[実施例] 次に実施例をあげて本発明をさらに詳細に説明する。本
発明はこれにより限定きれるものではない。配合量は重
量%である。
[Example] Next, the present invention will be explained in more detail by giving examples. The present invention is not limited thereby. The blending amount is in weight%.

尚、美白効果は、累積塗布による皮膚に対する色白効果
、シミ、ソバカスの解消などの使用テストから判定した
The whitening effect was determined from use tests such as the whitening effect on the skin after cumulative application, and the elimination of spots and freckles.

塗 による゛  果工 (試験方法) 色黒、しみ、そばかす等に悩む、被試験者、1群20名
として、1つの試料ローションを朝夕、3ケ月間、毎日
顔面に塗布し、3ケ月目にその美白効果を調べた。
(Test method) One group of 20 test subjects suffering from dark skin, age spots, freckles, etc. applied one sample lotion to their faces morning and evening every day for three months. We investigated its whitening effect.

(判定基準) 著  効:色素沈着がほとんど目立たなくなった。(Judgment criteria) Author: Effect: Pigmentation is almost invisible.

有  効:非常にうずくなった。Effective: Very tingling.

やや有効二ややうずくなった。I felt a little tingly.

無  効:変化無し く判定) 0:被試験者のうち著効、有効の示す割合(有効率)が
80%以上の場合 O:被試験者のうち著効、有効の示す割合(有効率)が
60x以上8oz未満の場合△:被試験者のうち著効、
有効の示す割合(有効率)が40%以上60%未満の場
合×:被試験者のうち著効、有効の示す割合(有効率)
が40χ未満の場合 実施例1、比較例1.2についてのべる。
(Ineffective: No change) 0: When the percentage of test subjects who show an excellent response or effective response (effective rate) is 80% or more O: The percentage of test subjects who show an excellent response or effective response (effective rate) is 60x or more and less than 8oz △: Among the test subjects, significant
If the percentage showing effectiveness (effective rate) is 40% or more and less than 60% ×: percentage of test subjects showing excellent response or effective (effective rate)
When is less than 40χ, Example 1 and Comparative Examples 1.2 will be described.

表1に示す配合組成よりなるローションを調整し、その
累積塗布による美白効果について調べた。
A lotion having the composition shown in Table 1 was prepared, and the whitening effect of cumulative application thereof was investigated.

処方と製法は以下のとおりである。即ち95X工チアル
コール10gに、POE(20)ラウリルエーテル0,
5gおよび香料を混合し、次いでこの中にあらかじめグ
リセリン2gとプロピレングリコール1gと、クエンF
20.2g、胎盤抽出物及びアルブチンとを加え、ざら
に、蒸留水を全重量が100gになるように必要量を添
加し混合して調整した。
The prescription and manufacturing method are as follows. That is, 10 g of 95X engineered alcohol, 0 of POE (20) lauryl ether,
5g and fragrance are mixed, and then 2g of glycerin, 1g of propylene glycol, and citric acid are mixed in advance.
20.2 g, placenta extract, and arbutin were added, and the necessary amount of distilled water was added to a colander so that the total weight was 100 g, and the mixture was adjusted.

(以下余白) 表1 実施例1、比較例1.2から明らかなように、本発明の
皮膚外用剤は美白効果に優れる新規な皮膚外用剤である
(The following is a blank space) Table 1 As is clear from Example 1 and Comparative Example 1.2, the skin external preparation of the present invention is a novel skin external preparation with excellent whitening effects.

実施例2  乳液 次の処方に従い、常法により乳液を製造した。Example 2 Emulsion A milky lotion was produced by a conventional method according to the following recipe.

POE (20)POP (2)セチルアルコールエー
テル 1.0シリコーンK F 96 (20cs)(
信越化学)2.0 流動パラフィン             3.0プロ
ピレングリコール          5.0グリセリ
ン              2.0エチルアルコー
ル            S、Oカルボキシビニルポ
リマー        0.3ヒドロキシプロピルセル
ロース      0.12−アミノメチルプロパツー
ル     0.1ブラセンタリキツド       
   1.0アルブチン              
 1.0防腐剤                 。
POE (20) POP (2) Cetyl alcohol ether 1.0 Silicone K F 96 (20cs) (
Shin-Etsu Chemical) 2.0 Liquid paraffin 3.0 Propylene glycol 5.0 Glycerin 2.0 Ethyl alcohol S, O carboxyvinyl polymer 0.3 Hydroxypropyl cellulose 0.12-Aminomethylpropanol 0.1 Blacenta liquid
1.0 arbutin
1.0 Preservative.

!香料                  適量イオ
ン交換水             残量実施例3  
乳液 次の処方に従い、常法により乳液を製造した。
! Fragrance Appropriate amount of ion exchange water Remaining amount Example 3
Emulsion A milky lotion was produced by a conventional method according to the following recipe.

POE (20) POP (2)セチルアルコールエ
ーテル1.0シリコーンK F 96 (20cs)(
信越化学)2.0 流動パラフィン             3.0プロ
ピレングリコール          5.0グリセリ
ン             2.0エチルアルコール
           15.0カルボキシビニルポリ
マー        0.3ヒドロキンプロピルセルロ
ース      0.12−アミノメチルプロパツール
      0.1ブラセンタリキツド       
    1.0アルブチン             
 10.0防腐剤                 
適量香料                  適量イ
オン交換水              残量実施例2
および3を実施例1と同様に累積塗布による美白効果を
測定した。結果を表2に示す。
POE (20) POP (2) Cetyl Alcohol Ether 1.0 Silicone K F 96 (20cs) (
Shin-Etsu Chemical) 2.0 Liquid paraffin 3.0 Propylene glycol 5.0 Glycerin 2.0 Ethyl alcohol 15.0 Carboxy vinyl polymer 0.3 Hydroquinepropylcellulose 0.12-Aminomethylpropanol 0.1 Blacente liquid
1.0 arbutin
10.0 Preservatives
Appropriate amount of fragrance Appropriate amount of ion exchange water Remaining amount Example 2
In the same manner as in Example 1, the whitening effect of the samples and 3 was measured by cumulative application. The results are shown in Table 2.

表2 実施例4  乳液 次の処方に従い、常法により乳液を製造した。Table 2 Example 4 Emulsion A milky lotion was produced by a conventional method according to the following recipe.

ステアリン酸              2.0セタ
ノール               1.0ワセリン
                3゜0ラノリンアル
コール           2,0流動パラフイン 
            8・0スクワラン     
          3.0エス力ロール507   
          2.0ブラセナンド■0.1 アルブチン               6.0PO
E(10)モノオレート           2.5
トリエタノールアミン          1.0プロ
ピレングリコール          5.0防腐剤 
                適量香料     
            適量蒸留水        
         残余実施例5  栄養クリーム 次の処方に従い、常法により栄養クリームを製造した。
Stearic acid 2.0 Cetanol 1.0 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin
8.0 squalane
3.0 S force roll 507
2.0 Brasenand ■0.1 Arbutin 6.0PO
E(10) monooleate 2.5
Triethanolamine 1.0 Propylene Glycol 5.0 Preservative
Appropriate amount of fragrance
Appropriate amount of distilled water
Remaining Example 5 Nutritional Cream A nutritional cream was produced by a conventional method according to the following recipe.

ステアリン酸              2.0ステ
アリルアルコール          7.0還元ラノ
リン              2・0スクワラン 
              5.0オクチルドテカノ
ール          6・0POE (25)セチ
ルエーテル         3.0グリセリルモノス
テアレート2.0 防腐剤                適量香料  
               適量プロピレングリコ
ール          5.01.3−ブチレングリ
コール         5.0プラセンタリキツド 
          2.0アルブチン       
       25.0蒸留水           
     残余実施例6  ビールオフ型バック 次の処方に従い、常法によりバックを製造した。
Stearic acid 2.0 Stearyl alcohol 7.0 Reduced lanolin 2.0 Squalane
5.0 Octyldotecanol 6.0 POE (25) Cetyl ether 3.0 Glyceryl monostearate 2.0 Preservative Appropriate amount Fragrance
Appropriate amount Propylene glycol 5.0 1.3-Butylene glycol 5.0 Placenta glycol
2.0 arbutin
25.0 distilled water
Remaining Example 6 Beer-off type bag A bag was manufactured by a conventional method according to the following recipe.

(アルコール相) 95%エタノール             10.0
POE (15)オレイルアルコールエーテル   2
.0防腐剤                適量香料
                 適量(水相) ブラセンA F               1.0
アルブチン              10.0  
’ポリビニルアルコール         12.0グ
リセリン              3.0ポリエチ
レングリコール1500       1.0イオン交
換水             残余(以下余白) 実施例7  乳液 次の処方に従い、常法により乳液を製造した。
(Alcohol phase) 95% ethanol 10.0
POE (15) Oleyl alcohol ether 2
.. 0 Preservatives Appropriate amount Fragrance Appropriate amount (aqueous phase) Bracene A F 1.0
Arbutin 10.0
'Polyvinyl alcohol 12.0 Glycerin 3.0 Polyethylene glycol 1500 1.0 Ion-exchanged water Remainder (hereinafter referred to as the margin) Example 7 Emulsion A milky lotion was produced by a conventional method according to the following recipe.

POE (20) POP (2)セチルアルコールエ
ーテル 1.0シリコーンK F 96 (20cs)
Ng越化学)2.0 流動パラフィン             3.0プロ
ピレングリコール          5゜Oグリセリ
ン              2.0エチルアルコー
ル    ・       15.0カルボキシビニル
ポリマー        0.3ヒドロキシプロピルセ
ルロース      0.12−アミノメチルプロパツ
ール     0.1ブラセンタリキツド      
     0.1八イドロキノ)−β−D−7ラピノー
ス                   20.0防
腐剤                適量香料   
               適量蒸留水     
            残量実施例4〜7の皮膚外用
剤は、累8N塗布による美白効果に優れていた。
POE (20) POP (2) Cetyl Alcohol Ether 1.0 Silicone K F 96 (20cs)
2.0 Liquid paraffin 3.0 Propylene glycol 5゜O glycerin 2.0 Ethyl alcohol ・15.0 Carboxy vinyl polymer 0.3 Hydroxypropyl cellulose 0.12-Aminomethyl propatool 0.1 Blacenta liquid
0.1 Octodoquino)-β-D-7 Rapinose 20.0 Preservative Appropriate amount Flavoring
Appropriate amount of distilled water
The skin external preparations of Examples 4 to 7 had excellent whitening effects when applied in cumulative amounts of 8N.

Claims (1)

【特許請求の範囲】 胎盤抽出物と、下記一般式であらわされるハイドロキノ
ンの配糖体とを含有することを特徴とする皮膚外用剤。 ▲数式、化学式、表等があります▼ [式中、Rは五炭糖残基、六炭糖残基、アミノ糖残基、
ウロン酸残基又はそれらのメチル化物を示す。]
[Scope of Claims] An external skin preparation characterized by containing a placenta extract and a hydroquinone glycoside represented by the following general formula. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [In the formula, R is a pentose residue, a hexose residue, an amino sugar residue,
Indicates uronic acid residues or their methylated products. ]
JP60049662A 1985-03-13 1985-03-13 External agent for skin Pending JPS61207315A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60049662A JPS61207315A (en) 1985-03-13 1985-03-13 External agent for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60049662A JPS61207315A (en) 1985-03-13 1985-03-13 External agent for skin

Publications (1)

Publication Number Publication Date
JPS61207315A true JPS61207315A (en) 1986-09-13

Family

ID=12837390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60049662A Pending JPS61207315A (en) 1985-03-13 1985-03-13 External agent for skin

Country Status (1)

Country Link
JP (1) JPS61207315A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63254181A (en) * 1987-04-09 1988-10-20 Kobayashi Kooc:Kk Antioxidant composition
JP2000095641A (en) * 1998-09-25 2000-04-04 Kanebo Ltd Bleaching preparation
JP2002179523A (en) * 2000-12-15 2002-06-26 Ichimaru Pharcos Co Ltd Cosmetic composition containing extract of swine placenta
JP2002187812A (en) * 2000-12-20 2002-07-05 Ichimaru Pharcos Co Ltd Cosmetic composition containing horse placenta extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5527883A (en) * 1978-08-21 1980-02-28 Kawasaki Heavy Ind Ltd Cement clinker burning apparatus
JPS6016906A (en) * 1983-07-07 1985-01-28 Pola Chem Ind Inc External drug for skin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5527883A (en) * 1978-08-21 1980-02-28 Kawasaki Heavy Ind Ltd Cement clinker burning apparatus
JPS6016906A (en) * 1983-07-07 1985-01-28 Pola Chem Ind Inc External drug for skin

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63254181A (en) * 1987-04-09 1988-10-20 Kobayashi Kooc:Kk Antioxidant composition
JPH0781140B2 (en) * 1987-04-09 1995-08-30 株式会社コーセー Antioxidant composition
JP2000095641A (en) * 1998-09-25 2000-04-04 Kanebo Ltd Bleaching preparation
JP2002179523A (en) * 2000-12-15 2002-06-26 Ichimaru Pharcos Co Ltd Cosmetic composition containing extract of swine placenta
JP2002187812A (en) * 2000-12-20 2002-07-05 Ichimaru Pharcos Co Ltd Cosmetic composition containing horse placenta extract

Similar Documents

Publication Publication Date Title
JP2764510B2 (en) Whitening cosmetics
EP0610511B2 (en) Composition for dermatologic preparation
JP2810107B2 (en) Cosmetic composition for skin
JPS61207316A (en) External agent for skin
JP2003160461A (en) Skin care preparation
JP2009067718A (en) Skin preparation for external use containing phenolic compound in sap of plant of aceraceae
JP2001026518A (en) Preparation composition for external use for skin
JPS61207315A (en) External agent for skin
JPH08268859A (en) Cosmetic for preventing and improving wrinkle
JP2805484B2 (en) External preparation for skin
JP2001278783A (en) Collagen production promoter
JPS61227515A (en) External preparation for skin
JP3004707B2 (en) External preparation for skin
JPH10279464A (en) Skin preparation for external use
JPH06321760A (en) Skin beautifying agent
JPS6289608A (en) External preparation for skin
JPS61227516A (en) External preparation for skin
JPH02207012A (en) Cosmetic for preventing skin from aging
JPH10279468A (en) Skin preparation for external use
JPH069366A (en) External agent for skin
JPH041115A (en) Dermal drug for external use
JP2982872B1 (en) External preparation for slimming skin
JP2860902B2 (en) External preparation for skin
JPH04169526A (en) Skin external medicine
JPH10194946A (en) Wrinkle improving agent and skin lotion